DK308187A - Farmaceutisk praeparat til beskyttelse af hjerneceller - Google Patents
Farmaceutisk praeparat til beskyttelse af hjernecellerInfo
- Publication number
- DK308187A DK308187A DK308187A DK308187A DK308187A DK 308187 A DK308187 A DK 308187A DK 308187 A DK308187 A DK 308187A DK 308187 A DK308187 A DK 308187A DK 308187 A DK308187 A DK 308187A
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical preparation
- brain cell
- cell protection
- protection
- brain
- Prior art date
Links
- 210000004958 brain cell Anatomy 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14159386 | 1986-06-18 | ||
| JP1387687 | 1987-01-23 | ||
| JP62136460A JPH0713017B2 (ja) | 1986-06-18 | 1987-05-30 | 脳細胞保護作用を有する医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK308187D0 DK308187D0 (da) | 1987-06-17 |
| DK308187A true DK308187A (da) | 1987-12-19 |
Family
ID=27280439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK308187A DK308187A (da) | 1986-06-18 | 1987-06-17 | Farmaceutisk praeparat til beskyttelse af hjerneceller |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4804657A (da) |
| EP (1) | EP0250241B1 (da) |
| JP (1) | JPH0713017B2 (da) |
| AU (1) | AU603363B2 (da) |
| DE (1) | DE3768150D1 (da) |
| DK (1) | DK308187A (da) |
| NZ (1) | NZ220747A (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2057110T3 (es) * | 1988-03-24 | 1994-10-16 | Sankyo Co | Utilizacion de isoxazolinonas como farmacos con accion sobre el cerebro. |
| US5066662A (en) * | 1990-05-21 | 1991-11-19 | Warner-Lambert Company | Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors |
| DE4324393A1 (de) * | 1993-07-21 | 1995-01-26 | Merck Patent Gmbh | 4-Aryloxy- und 4-Arylthiopiperidinderivate |
| DE19531321A1 (de) * | 1995-08-25 | 1997-02-27 | Merck Patent Gmbh | Piperidinylmethyloxazolidinone |
| US6159990A (en) * | 1997-06-18 | 2000-12-12 | Synaptic Pharmaceutical Corporation | Oxazolidinones as α1A receptor antagonists |
| AU740064B2 (en) * | 1997-06-18 | 2001-10-25 | H. Lundbeck A/S | Heterocyclic substituted piperidines and uses thereof |
| US6319932B1 (en) | 1998-11-10 | 2001-11-20 | Merck & Co., Inc. | Oxazolidinones useful as alpha 1A adrenoceptor antagonists |
| US6228870B1 (en) | 1998-11-10 | 2001-05-08 | Merck & Co., Inc. | Oxazolidinones useful as alpha 1a adrenoceptor antagonists |
| JPWO2003031414A1 (ja) * | 2001-10-03 | 2005-01-20 | 日本曹達株式会社 | 新規なヘテロ環化合物および抗炎症薬 |
| EP3020710A4 (en) * | 2013-07-11 | 2016-12-14 | Consejo Superior De Investig Científicas (Csic) | OXAZOLIDINONE DERIVATIVES AS PPAR LIGANDS |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6183170A (ja) * | 1984-09-28 | 1986-04-26 | Nippon Chemiphar Co Ltd | 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法 |
-
1987
- 1987-05-30 JP JP62136460A patent/JPH0713017B2/ja not_active Expired - Lifetime
- 1987-06-17 DK DK308187A patent/DK308187A/da not_active Application Discontinuation
- 1987-06-18 EP EP87305418A patent/EP0250241B1/en not_active Expired - Lifetime
- 1987-06-18 US US07/063,379 patent/US4804657A/en not_active Expired - Fee Related
- 1987-06-18 AU AU74484/87A patent/AU603363B2/en not_active Ceased
- 1987-06-18 NZ NZ220747A patent/NZ220747A/xx unknown
- 1987-06-18 DE DE8787305418T patent/DE3768150D1/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE3768150D1 (de) | 1991-04-04 |
| EP0250241A1 (en) | 1987-12-23 |
| AU7448487A (en) | 1987-12-24 |
| JPH0713017B2 (ja) | 1995-02-15 |
| JPS63301819A (ja) | 1988-12-08 |
| DK308187D0 (da) | 1987-06-17 |
| AU603363B2 (en) | 1990-11-15 |
| US4804657A (en) | 1989-02-14 |
| EP0250241B1 (en) | 1991-02-27 |
| NZ220747A (en) | 1990-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK664387A (da) | Fremgangsmaade til fremstilling af et anti-inflammatorisk farmaceutisk praeparat | |
| DK195988D0 (da) | Farmaceutisk praeparat indeholdende mikrokapsler | |
| DK186688D0 (da) | Fremgangsmaade til dyrkning af leukocytter | |
| DK380986A (da) | Fremgangsmaade til fremstilling af piperidinderivater | |
| DK91487D0 (da) | Forbedret fremgangsmaade til paafoering af beskyttelseslag | |
| DK147787D0 (da) | Forbedret fremgangsmaade til paafoering af beskyttelseslag | |
| DK138287A (da) | Fremgangsmaade til fremstilling af ensilage | |
| DK308187A (da) | Farmaceutisk praeparat til beskyttelse af hjerneceller | |
| DK427887A (da) | Farmaceutisk praeparat til beskyttelse af hjerneceller | |
| DK537687D0 (da) | Fremgangsmaade til fremstilling af n-substituerede piperazinoner | |
| DK39789D0 (da) | Fremgangsmaade til fremstilling af n-phosphonmethyliminodieddikesyre | |
| DK509587A (da) | Fremgangsmaade til inhibering af genekspression | |
| DK343386A (da) | Fremgangsmaade til fremstilling af 2-cyanamino-pyrimidin-derivater | |
| DK329787A (da) | Fremgangsmaade til fremstilling af mercaptoacylprolinderivater | |
| DK184687D0 (da) | Fremgangsmaade til fremstilling af diacetonesorbose | |
| DK361387D0 (da) | Fremgangsmaade til fremstilling af piperidinopyrimidin | |
| DK533287A (da) | Fremgangsmaade til fremstilling af azetidinoner | |
| DK350288D0 (da) | Fremgangsmaade til fremstilling af n-epoxypropyllactamer | |
| DK587287D0 (da) | Fremgangsmaade til fremstilling af 2-guanidinotiazolderivater | |
| DK98287A (da) | Fremgangsmaade til fremstilling af imidazolylthiophenaldehyder | |
| DK987D0 (da) | Fremgangsmaade til fremstilling af tetrachlorpyri- din | |
| DK428287A (da) | Nasalt farmaceutisk praeparat | |
| DK234687A (da) | Fremgangsmaade til fremstilling af ribitylxylidin | |
| DK430986D0 (da) | Faldsikring til lamelporte | |
| DK154220C (da) | Fremgangsmaade til fremstilling af etoposid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |